An unanticipated role for survivin in organ transplant damage

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 1046-1060

  Cassis, P ^a   Solini, S ^a   Azzollini, N ^a   Aiello, S ^a   Rocchetta, F ^a   Conti, S ^a   Novelli, R ^a   Gagliardini, E ^a   Mister, M ^a   Rapezzi, F ^a   Rapezzi, S ^a   Benigni, A ^a   Remuzzi, G ^a,b   Conway, E M ^c   Noris, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic allograft injury; gene therapy; ischemia reperfusion injury; kidney transplantation; survivin

Indexed keywords

CXCL2 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; SURVIVIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; BIRC5 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; REPRESSOR PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GRAFT FAILURE; GRAFT SURVIVAL; HAPLOINSUFFICIENCY; HUMORAL IMMUNITY; INFLAMMATION; ISOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL GRAFT DYSFUNCTION; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; TREATMENT OUTCOME; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; DONOR; GENE TRANSFER; GRAFT REJECTION; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; INFLAMMATION; INHIBITOR OF APOPTOSIS PROTEINS; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY; REPRESSOR PROTEINS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84898939812     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12677     Document Type: Article

References (37)

1. Bonventre JV, Yang L., Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210-4221.
2. Noris M, Cassis P, Azzollini N, et al. The toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol 2009; 183: 4249-4260.
3. Salahudeen AK, Haider N, May W., Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004; 65: 713-718.
4. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR., Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24: 1039-1047.
5. Altieri DC., Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010; 430: 199-205.
6. Altieri DC., Survivin cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61-70.
7. Lens SM, Vader G, Medema RH., The case for survivin as mitotic regulator. Curr Opin Cell Biol 2006; 18: 616-622.
8. Li F, Brattain MG., Role of the survivin gene in pathophysiology. Am J Pathol 2006; 169: 1-11.
9. Zwerts F, Lupu F, De Vriese A, et al. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood 2007; 109: 4742-4752.
10. Conway EM, Pollefeyt S, Steiner-Mosonyi M, et al. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 2002; 123: 619-631.
11. Lechler P, Wu X, Bernhardt W, et al. The tumor gene survivin is highly expressed in adult renal tubular cells: Implications for a pathophysiological role in the kidney. Am J Pathol 2007; 171: 1483-1498.
12. Si R, Tao L, Zhang HF, et al. Survivin: A novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 2010; 50: 16-24.
13. Santini D, Abbate A, Scarpa S, et al. Surviving acute myocardial infarction: Survivin expression in viable cardiomyocytes after infarction. J Clin Pathol 2004; 57: 1321-1324.
14. Conway EM, Zwerts F, Van Eygen V, et al. Survivin-dependent angiogenesis in ischemic brain: Molecular mechanisms of hypoxia-induced up-regulation. Am J Pathol 2003; 163: 935-946.
15. Humphreys BD, Czerniak S, DiRocco DP, Hasnain W, Cheema R, Bonventre JV., Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011; 108: 9226-9231.
16. Westhoff JH, Schildhorn C, Jacobi C, et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21: 327-336.
17. Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriese A, Conway EM., Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J 2008; 22: 510-521.
18. Chen J, Chen JK, Conway EM, Harris RC., Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol 2013; 24: 2023-2033.
19. Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C., Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J 2002; 21: 2602-2615.
20. Fortugno P, Beltrami E, Plescia J, et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 2003; 100: 13791-13796.
21. Song Z, Yao X, Wu M., Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 2003; 278: 23130-23140.
22. Ceballos-Cancino G, Espinosa M, Maldonado V, Melendez-Zajgla J., Regulation of mitochondrial Smac/DIABLO-selective release by survivin. Oncogene 2007; 26: 7569-7575.
23. Boros P, Bromberg JS., New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 2006; 6: 652-658.
24. Mannon RB., Macrophages: Contributors to allograft dysfunction, repair, or innocent bystanders ? Curr Opin Organ Transplant 2012; 17: 20-25.
25. Kang BH, Xia F, Pop R, Dohi T, Socolovsky M, Altieri DC., Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein. J Biol Chem 2011; 286: 16758-16767.
26. Mita AC, Mita MM, Nawrocki ST, Giles FJ., Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5005.
27. Arslan F, Keogh B, McGuirk P, Parker AE., TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010; 2010: 704202.
28. Blanc-Brude OP, Teissier E, Castier Y, et al. IAP survivin regulates atherosclerotic macrophage survival. Arterioscler Thromb Vasc Biol 2007; 27: 901-907.
29. Satpute SR, Park JM, Jang HR, et al. The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury. J Immunol 2009; 183: 984-992.
30. Fuquay R, Renner B, Kulik L, et al. Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol 2013; 24: 1063-1072.
31. Solini S, Aiello S, Cassis P, et al. Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantation. Transpl Int 2012; 25: 347-356.
32. Yates PJ, Nicholson ML., The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006; 16: 148-157.
33. Forbes JM, Hewitson TD, Becker GJ, Jones CL., Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat. Kidney Int 2000; 57: 2375-2385.
34. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV., Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543, 1p following 143.
35. Li F, Altieri DC., Transcriptional analysis of human survivin gene expression. Biochem J 1999; 344: 305-311.
36. Ryan BM, O'Donovan N, Duffy MJ., Survivin: A new target for anti-cancer therapy. Cancer Treat Rev 2009; 35: 553-562.
37. Dohi T, Salz W, Costa M, Ariyan C, Basadonna GP, Altieri DC., Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep 2006; 7: 438-443.